Parties d'ouvrages collectifs (4)
  1. 1. Compte, N., Pepersack, T., & Goriely, S. (2018). Frailty in old Age is associated with altered cytokine production in response to TLR ligation. In T. Fulöp, C. Franceschi, K. Hirokawa, & G. Pawelec (Eds.), Handbook of Immunosenescence: Basic Understanding and Clinical Implications (pp. 1-18). Springer. doi:10.1007/978-3-319-64597-1_152-1
  2. 2. Welsby, I., & Goriely, S. (2016). Regulation of Interleukin-23 Expression in Health and Disease. In Advances in Experimental Medicine and Biology, Vol. 941. Regulation of Cytokine Gene Expression in Immunity and Diseases (pp. 167-189). Springer.
  3. 3. Compte, N., & Goriely, S. (2012). Innate immune responses in the geriatric population. In J. R. Kanwar (Ed.), Recent Advances in Immunology to Target Cancer, Inflammation and Infections.
  4. 4. Goriely, S., De Wit, D., Goldman, M., & Willems, F. (2008). Toll like receptor responses in neonatal dendritic cells. In R. Ohls & M. Yoder (Eds.), Neonatalogy, Questions and Controversies Series: Hematology, Immunology, Infectious Disease (pp. 106-134). Saunders-Elsevier. doi:10.1016/B978-141603158-1.10008-3
    5.   Articles dans des revues avec comité de lecture (91)
  5. 1. Musrati, M. A., Stijlemans, B., Azouz, A., Kancheva, D., Mesbahi, S., Hadadi, E., Lebegge, E., Ali, L., De Vlaminck, K., Scheyltjens, I., Vandamme, N., Zivalj, M., Assaf, N., Elkrim, Y., Ahmidi, I., Huart, C., Lamkanfi, M., Guilliams, M., De Baetselier, P., Goriely, S., Movahedi, K., & Van Ginderachter, J. A. (2024). Infection history imprints prolonged changes to the epigenome, transcriptome and function of Kupffer cells. Journal of hepatology. doi:10.1016/j.jhep.2024.07.007
  6. 2. Englebert, K., Taquin, A., Azouz, A., Acolty, V., Vande Velde, S., Vanhollebeke, M., Innes, H., Boon, L., Keler, T., Leo, O., Goriely, S., Moser, M., & Oldenhove, G. (2024). The CD27/CD70 pathway negatively regulates visceral adipose tissue-resident Th2 cells and controls metabolic homeostasis. Cell reports, 43(3), 113824. doi:10.1016/j.celrep.2024.113824
  7. 3. Le Moine, M., Azouz, A., Sánchez Sánchez, G., Dejolier, S., Nguyen, M., Thomas, S., Shala, V., Dreidi, H., Denanglaire, S., Libert, F., Vermijlen, D., Andris, F., & Goriely, S. (2023). Homeostatic PD-1 signaling restrains EOMES-dependent oligoclonal expansion of liver-resident CD8 T cells. Cell reports, 42(8), 112876. doi:10.1016/j.celrep.2023.112876
  8. 4. Bowakim-Anta, N., Acolty, V., Azouz, A., Yagita, H., Leo, O., Goriely, S., Oldenhove, G., & Moser, M. (2023). Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs. Frontiers in immunology, 14, 1023064. doi:10.3389/fimmu.2023.1023064
  9. 5. Mirzaei, M., Dodi, G., Gardikiotis, I., Pasca, S.-A., Mirdamadi, S., Subra, G., Echalier, C., Puel, C., Morent, R., Ghobeira, R., Soleymanzadeh, N., Moser, M., Goriely, S., & Shavandi, A. (2023). 3D high-precision melt electro written polycaprolactone modified with yeast derived peptides for wound healing. Biomaterials Advances, 149, 213361. doi:10.1016/j.bioadv.2023.213361
  10. 6. Bisilliat Donnet, C., Acolty, V., Azouz, A., Taquin, A., Henin, C., Cafarello, S. T., Denanglaire, S., Mazzone, M., Oldenhove, G., Leo, O., Goriely, S., & Moser, M. (2023). PHD2 Constrains Antitumor CD8+ T-cell Activity. Cancer immunology research, 11(3), 339-350. doi:10.1158/2326-6066.CIR-22-0099
  11. 7. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  12. 8. Sánchez Sánchez, G., Papadopoulou, M., Azouz, A., Tafesse, Y., Mishra, A., Chan, J. K. Y., Fan, Y., Verdebout, I., Porco, S., Libert, F., Ginhoux, F., Vandekerckhove, B., Goriely, S., & Vermijlen, D. (2022). Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. Nature communications, 13(1), 5842. doi:10.1038/s41467-022-33488-2
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>